Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer
Abstract Hypopharyngeal squamous cell carcinoma (HPSCC) has a very poor prognosis. Local surgery may increase survival, but is often avoided due to significant post-op co-morbidities. Since prognostic markers are lacking, the aim was to find predictive biomarkers that identify patients whose respons...
Saved in:
Main Authors: | Michael Mints, David Landin, Anders Näsman, Leila Mirzaie, Ramona Gabriela Ursu, Mark Zupancic, Linda Marklund, Tina Dalianis, Eva Munck-Wikland, Torbjörn Ramqvist |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7b38a5f9949a4258a73607c31b9902d9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oropharynx microbiota transitions in hypopharyngeal carcinoma treatment of induced chemotherapy followed by surgery
by: Hui-Ching Lau, et al.
Published: (2021) -
CD271 defines a stem cell-like population in hypopharyngeal cancer.
by: Takayuki Imai, et al.
Published: (2013) -
Prognostic value of α2δ1 in hypopharyngeal carcinoma: A retrospective study
by: Liu Qiang, et al.
Published: (2021) -
A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma
by: Qi Zhong, et al.
Published: (2018) -
INTERRELATIONSHIP BETWEEN EFFICIENCY OF CANCER TREATMENT AND STATE OF IMMUNE SYSTEM IN PATIENTS WITH LARYNGEAL AND HYPOPHARYNGEAL CANCER
by: M. N. Stakheyeva, et al.
Published: (2014)